+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticonvulsants"

From
From
From
Dravet Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Dravet Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Trigeminal Neuralgia - Pipeline Insight, 2024 - Product Thumbnail Image

Trigeminal Neuralgia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
T type calcium channel antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

T type calcium channel antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
Global Infantile Spasms Therapeutics Market 2024-2028 - Product Thumbnail Image

Global Infantile Spasms Therapeutics Market 2024-2028

  • Report
  • December 2023
  • 154 Pages
  • Global
From
Loading Indicator

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics. The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more